EUVIMEDEUVIMED entdecken
Crossref

Short-term γ-aminobutyric acid antagonist treatment improves long-term sleep quality, memory, and decision-making in a Down syndrome mouse model

Elsa C Pittaras iD, Jonathan M Artal, Grace Ajibola, Giancarlo Allocca, Mia Bennett, Alexandra Camargo, Angelica Carpio, Nicholas Gessner, Myles Hinton, Rebecca Pizzitola iD, Natalie Tan iD, Evelyn Zhang und 2 weitere

SLEEP · 2025

DOI: 10.1093/sleep/zsae300 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SLEEP, 2025. Verfasst von Elsa C Pittaras und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Stanford University, Stanford, CA, USA. Hauptthemen laut MEDLINE: Down Syndrome, Decision Making, GABA Antagonists, Sleep Quality. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: NIMH NIH HHS, Non-Federal funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Down syndrome (DS) is a common genetic condition affecting people worldwide. It involves cognitive disabilities for which there are no drug therapies. The Ts65Dn mouse model of DS shows cognitive impairment due to a reduction in neuron number and connectivity as well as excessive neuronal activity, as γ-aminobutyric acid (GABA) antagonist treatment restores memory in these mice. Our study showed the effects of GABA antagonist treatment on sleep and decision-making in Ts65Dn mice. We administered a daily, low oral dose of pentylenetetrazol (PTZ) in milk to Ts65Dn mice for 17 days. Decision-making was tested with and without PTZ treatment. Short and long-term memories were tested before, immediately after, and 1 month following PTZ treatment. Electro-encephalography was also recorded at these three time points to study the effect of the treatment on sleep. We showed that PTZ treatment improved long-term recognition, but not short term memory and led to more Ts65Dn mice showing safer decision-making behavior. PTZ treatment showed a moderate and only global beneficial effect on sleep by decreasing the global amount of wake and increasing non-rapid eye movement sleep in the Ts65Dn mice, which may explain the observed cognitive improvements. These results bring new knowledge on the role of GABA in sleep, memory consolidation, and decision-making abilities in DS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Down SyndromeDecision MakingGABA AntagonistsSleep QualityMemoryAnimalsMiceDisease Models, AnimalPentylenetetrazoleElectroencephalographyMaleMemory, Short-Term

Stichwörter der Autor:innen

EEG analysiscognitive functionlearning and memoryneuropharmacologysleep/wake cognition

Substanzen

PentylenetetrazoleGABA Antagonists

Autor:innen und Institutionen

  • Department of Biology, Stanford University, Stanford, CA, USA.
  • Stanford Law School, Stanford University, Stanford, CA, USA.
  • The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.
  • School of Biomedical Sciences, University of Melbourne, Parkville, Victoria, Australia.
  • Somnivore Pty. Ltd., Bacchus Marsh, Victoria, Australia.
  • Department of Human Biology, School of Humanities and Sciences, Stanford University, Stanford, CA, USA.

ORCID-Profile: Elsa C Pittaras, Rebecca Pizzitola, Natalie Tan

Förderung

  • NIMH NIH HHS
  • Non-Federal funding

Zitieren

APA

Pittaras, E. C., Artal, J. M., Ajibola, G., Allocca, G., Bennett, M., Camargo, A., Carpio, A., Gessner, N., Hinton, M., Pizzitola, R., Tan, N., Zhang, E., Zhong, A., & Heller, H. C. (2025). Short-term γ-aminobutyric acid antagonist treatment improves long-term sleep quality, memory, and decision-making in a Down syndrome mouse model. SLEEP. https://doi.org/10.1093/sleep/zsae300

Vancouver

Pittaras EC, Artal JM, Ajibola G, Allocca G, Bennett M, Camargo A, et al. Short-term γ-aminobutyric acid antagonist treatment improves long-term sleep quality, memory, and decision-making in a Down syndrome mouse model. SLEEP. 2025. doi:10.1093/sleep/zsae300

BibTeX
@article{Pittaras2025,
  author = {Pittaras, Elsa C and Artal, Jonathan M and Ajibola, Grace and Allocca, Giancarlo and Bennett, Mia and Camargo, Alexandra and Carpio, Angelica and Gessner, Nicholas and Hinton, Myles and Pizzitola, Rebecca and Tan, Natalie and Zhang, Evelyn and Zhong, Alan and Heller, Horace C},
  title = {Short-term γ-aminobutyric acid antagonist treatment improves long-term sleep quality, memory, and decision-making in a Down syndrome mouse model},
  journal = {SLEEP},
  year = {2025},
  doi = {10.1093/sleep/zsae300}
}
Kostenlos starten →